Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Global Health and Lincoln Park team up

This article was originally published in The Tan Sheet

Executive Summary

Specialty pharmaceutical firm Global Health Ventures signs an equity purchase agreement with Lincoln Park Capital Fund for up to $20 million, the Canadian maker of sublingually delivered lifestyle products said May 28. Global Health says it has the right to sell shares of common stock to the Chicago-based institutional investor over a 30-month period in amounts between $100,000 and $1 million, and up to the $20 million limit depending on conditions of the agreement. Global Health says the finance proceeds will help it develop the male enhancement drug X-Excite and other drugs, license new products and acquire other companies
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS104181

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel